Castle Biosciences Inc. (CSTL) Stock: Dividends & Earnings

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $17.72 - $44.28

7.2 Year CSTL Performance Metrics:

Total Return (with DRIP): 66.0% (7.30% CAGR)

Total Return (no DRIP): 66.0% (7.30% CAGR)

Share Price: 66.0% (7.30% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $16,603

Total Return $ (with DRIP): $6,603

CSTL Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

CSTL Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for CSTL

Based on past 7.2-year performance, here are CSTL growth metrics:

Share price CAGR of +7.3%
Dividend CAGR of +0%

Using CSTL CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	CSTL (DRIP)	CSTL - No DRIP
Current Price	$35.53	$35.53
Start Shares	281.45	281.45
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	281.45	281.45
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$35.53	$35.53
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - CSTL

NOTE: Above numbers are our estimate based on CSTL's Dividend and Price CAGR over past 7.2 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Castle Biosciences Inc. (CSTL) had its IPO on , and is traded on NASDAQ stock exchange.

Castle Biosciences Inc. is a molecular diagnostics company that develops and commercializes proprietary tests designed to support clinical decision-making. The company focuses primarily on dermatologic cancers, including melanoma and cutaneous squamous cell carcinoma, while also serving gastroenterology, ophthalmology, and certain mental health applications. Its portfolio includes tests used to help assess risk, refine diagnosis, and guide treatment choices through clinically actionable genomic and molecular information. Castle Biosciences works with physicians, specialty clinics, hospitals, and health systems that rely on specialized testing to better manage complex diseases and personalize care. The company’s role in the market centers on translating laboratory science into practical tools that can improve how patients are evaluated and treated across several high-need medical areas.

CSTL website: https://castlebiosciences.com